Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Armstrong

Showing results (1461-1470 of 2,037) with videos related to

Pageof 204
Sort By:
Advances in Therapy|February 20, 2024
Evolving Role of Viltolarsen for Treatment of Duchenne Muscular DystrophyLeighAnn Y Vincik, Alexandra D Dautel, Abigail A Staples, et al.
Journal of Hepatology|June 28, 2011
Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohortMatthew J Armstrong, Diarmaid D Houlihan, Louise Bentham, et al.
Pediatrics|April 1, 1990
Immunogenicity of a new Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB)P P Vella, J M Staub, J Armstrong, et al.
NPJ Precision Oncology|February 24, 2023
Rewiring of the N-Glycome with prostate cancer progression and therapy resistanceWilliam Butler, Colin McDowell, Qing Yang, et al.
Journal of the American Heart Association|April 12, 2014
Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial diseaseEhrin J Armstrong, Debbie C Chen, Gregory G Westin, et al.
Prostate Cancer and Prostatic Diseases|June 3, 2005
Bicalutamide ('Casodex') 150 mg in addition to standard care in patients with nonmetastatic prostate cancer: updated results from a randomised double-blind phase III study (median follow-up 5.1 y) in the early prostate cancer programmeM Wirth, C Tyrrell, K Delaere, et al.
Clinical Genitourinary Cancer|July 9, 2013
A phase II trial of temsirolimus in men with castration-resistant metastatic prostate cancerAndrew J Armstrong, Tong Shen, Susan Halabi, et al.
The American Journal of Cardiology|April 27, 2012
Delaying primary percutaneous coronary intervention for computed tomographic scans in the emergency departmentEhrin J Armstrong, Ameya R Kulkarni, Kurt S Hoffmayer, et al.
JACC. Cardiovascular Interventions|October 6, 2018
WIRION Embolic Protection System in Lower Extremity Arterial Interventions: Results of the Pivotal WISE LE TrialNicolas W Shammas, Anthony Pucillo, J Stephen Jenkins, et al.
Parkinsonism & Related Disorders|March 19, 2024
OFF episode quality of life impact scale (OFFELIA): A new measure of quality of life for off episodes in Parkinson's diseaseMaja Kuharic, Victoria Kulbokas, Kent Hanson, et al.
Pageof 204

Showing results (1461-1470 of 2,037) with videos related to

Sort By:
Pageof 204
Advances in Therapy|February 20, 2024
Evolving Role of Viltolarsen for Treatment of Duchenne Muscular DystrophyLeighAnn Y Vincik, Alexandra D Dautel, Abigail A Staples, et al.
Journal of Hepatology|June 28, 2011
Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohortMatthew J Armstrong, Diarmaid D Houlihan, Louise Bentham, et al.
Pediatrics|April 1, 1990
Immunogenicity of a new Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB)P P Vella, J M Staub, J Armstrong, et al.
NPJ Precision Oncology|February 24, 2023
Rewiring of the N-Glycome with prostate cancer progression and therapy resistanceWilliam Butler, Colin McDowell, Qing Yang, et al.
Journal of the American Heart Association|April 12, 2014
Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial diseaseEhrin J Armstrong, Debbie C Chen, Gregory G Westin, et al.
Prostate Cancer and Prostatic Diseases|June 3, 2005
Bicalutamide ('Casodex') 150 mg in addition to standard care in patients with nonmetastatic prostate cancer: updated results from a randomised double-blind phase III study (median follow-up 5.1 y) in the early prostate cancer programmeM Wirth, C Tyrrell, K Delaere, et al.
Clinical Genitourinary Cancer|July 9, 2013
A phase II trial of temsirolimus in men with castration-resistant metastatic prostate cancerAndrew J Armstrong, Tong Shen, Susan Halabi, et al.
The American Journal of Cardiology|April 27, 2012
Delaying primary percutaneous coronary intervention for computed tomographic scans in the emergency departmentEhrin J Armstrong, Ameya R Kulkarni, Kurt S Hoffmayer, et al.
JACC. Cardiovascular Interventions|October 6, 2018
WIRION Embolic Protection System in Lower Extremity Arterial Interventions: Results of the Pivotal WISE LE TrialNicolas W Shammas, Anthony Pucillo, J Stephen Jenkins, et al.
Parkinsonism & Related Disorders|March 19, 2024
OFF episode quality of life impact scale (OFFELIA): A new measure of quality of life for off episodes in Parkinson's diseaseMaja Kuharic, Victoria Kulbokas, Kent Hanson, et al.
Pageof 204